Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALBAVANCIN for Soft tissue infection: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where DALBAVANCIN was used for Soft tissue infection.

Most Reported Side Effects for DALBAVANCIN

Side Effect Reports % Deaths Hosp.
Off label use 192 17.3% 14 43
Rash 99 8.9% 1 17
Pruritus 64 5.8% 0 11
Dyspnoea 62 5.6% 1 22
Back pain 61 5.5% 0 6
Erythema 56 5.1% 1 16
Vomiting 54 4.9% 0 14
Hypersensitivity 49 4.4% 0 15
Nausea 45 4.1% 0 13
Drug ineffective 44 4.0% 2 16
Pyrexia 42 3.8% 2 22
Acute kidney injury 41 3.7% 1 23
Urticaria 38 3.4% 0 4
Diarrhoea 35 3.2% 0 10
Infusion related reaction 30 2.7% 0 13

Other Indications for DALBAVANCIN

Product used for unknown indication (304) Cellulitis (143) Osteomyelitis (104) Staphylococcal infection (85) Infection (60) Skin infection (52) Endocarditis (35) Device related infection (33) Skin bacterial infection (32) Bacteraemia (25)

Other Drugs Used for Soft tissue infection

PIPERACILLIN\TAZOBACTAM (59) LINEZOLID (57) VANCOMYCIN (52) SULFAMETHOXAZOLE\TRIMETHOPRIM (46) CLINDAMYCIN (39) DAPTOMYCIN (31) LEVOFLOXACIN (26) AMOXICILLIN\CLAVULANIC ACID (20) CUBICIN (14) CEFTRIAXONE (13)

Related Pages

DALBAVANCIN Full Profile All Soft tissue infection Drugs DALBAVANCIN Demographics DALBAVANCIN Timeline